249 studies found for:    Open Studies | "Macular Degeneration"
Show Display Options
Rank Status Study
21 Not yet recruiting A Study of Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular Degeneration
Condition: Neovascular Age-Related Macular Degeneration
Intervention: Drug: TK001
22 Not yet recruiting Development of Core Outcomes for Age-related Macular Degeneration (AMD) Interventions- Caregivers' Perspective
Condition: Age Related Macular Degeneration
Intervention: Behavioral: Focus Groups
23 Recruiting The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD)
Condition: Age Related Macular Degeneration
Intervention: Genetic: metagenome
24 Recruiting Cytokeratin 8 Level in Age-related Macular Degeneration
Condition: Age-related Macular Degeneration
Intervention: Drug: Ranibizumab
25 Recruiting Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy
Condition: Wet Macular Degeneration
Intervention: Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
26 Not yet recruiting Transpalpebral Micro Current Electrical Stimulation for the Treatment of Dry Age-Related Macular Degeneration
Condition: Age-related Macular Degeneration
Interventions: Device: Nova Oculus™ Micro-current electrical stimulation;   Device: Nova Oculus™ Micro-current electrical stimulation - Sham treatment
27 Recruiting Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention: Other: No interventions are planned
28 Recruiting Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration
Condition: Age Related Macular Degeneration
Interventions: Device: LT-300 Active (PBM);   Device: LT-300 Inactive (Sham)
29 Recruiting Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients
Condition: Age Related Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Bevacizumab;   Drug: Aflibercept;   Other: Control Group
30 Recruiting An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention: Drug: Elamipretide
31 Recruiting Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Condition: Age-Related Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Aflibercept
32 Recruiting Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Interventions: Drug: Squalamine Lactate Ophthalmic Solution, 0.2%;   Drug: Placebo Ophthalmic Solution;   Drug: ranibizumab
33 Recruiting Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)
Condition: Age-Related Macular Degeneration
Intervention: Drug: SF0166 Topical Ophthalmic Solution
34 Recruiting Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration
Condition: Age-Related Macular Degeneration
Intervention:
35 Recruiting Non-exudative Age-related Macular Degeneration
Condition: Non-exudative Age-related Macular Degeneration
Intervention:
36 Recruiting Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration
Condition: Neovascular Age-related Macular Degeneration
Intervention: Drug: Ranibizumab
37 Recruiting Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration
Condition: Age-related Macular Degeneration (AMD)
Intervention: Biological: ranibizumab
38 Recruiting Anti-angiOpoeitin 2 Plus Anti-vascular eNdothelial Growth Factor as a therapY for Neovascular Age Related Macular Degeneration: Evaluation of a fiXed Combination Intravitreal Injection
Condition: Neovascular Age-Related Macular Degeneration
Interventions: Drug: REGN910-3;   Drug: Intravitreal Aflibercept Injection (IAI)
39 Recruiting Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular Degeneration
Condition: Age- Related Macular Degeneration
Interventions: Drug: Minocycline;   Other: Placebo
40 Recruiting Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
Condition: Age-related Macular Degeneration
Intervention: Biological: OpRegen

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.